These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1448 related items for PubMed ID: 21920556

  • 1. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y, Liu J, Xu C, Zhang W, Bai L, Li N, Liu Y, Wang Y, Su Y, Hu D.
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [Abstract] [Full Text] [Related]

  • 2. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Han Y, Yang L, Guo S.
    J Surg Res; 2010 May 15; 160(2):315-24. PubMed ID: 19524257
    [Abstract] [Full Text] [Related]

  • 3. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN, Lee J, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Kwon CH, Joh JW, Kim SJ.
    J Surg Res; 2006 Jan 15; 130(1):102-9. PubMed ID: 16183077
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance.
    Deng W, Han Q, Liao L, Li C, Ge W, Zhao Z, You S, Deng H, Zhao RC.
    Exp Hematol; 2004 Sep 15; 32(9):861-7. PubMed ID: 15345288
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL, Wren SM, Schuchert MJ, Patrene KD, Johnson PC, Boggs SS, Ildstad ST.
    J Immunol; 1995 Nov 01; 155(9):4179-88. PubMed ID: 7594573
    [Abstract] [Full Text] [Related]

  • 9. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M.
    Biol Blood Marrow Transplant; 2001 Nov 01; 7(12):646-55. PubMed ID: 11787527
    [Abstract] [Full Text] [Related]

  • 10. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H, Abe M, Shirai T, Fukao K, Nakauchi H.
    J Immunol; 1995 Dec 15; 155(12):5631-6. PubMed ID: 7499847
    [Abstract] [Full Text] [Related]

  • 11. Combined treatment with regulatory T cells and vascularized bone marrow transplantation creates mixed chimerism and induces donor-specific tolerance to vascularized composite allografts without cytoreductive conditioning.
    Lin JY, Tsai FC, Wallace CG, Huang WC, Wei FC, Liao SK.
    J Surg Res; 2012 Dec 15; 178(2):974-81. PubMed ID: 22819314
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM, Gorechlad J, Larsen CP, Waller EK.
    Biol Blood Marrow Transplant; 2006 Dec 15; 12(12):1239-49. PubMed ID: 17162205
    [Abstract] [Full Text] [Related]

  • 14. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T, Tomita Y, Zhang QW, Shimizu I, Nomoto K, Yasui H.
    Transpl Int; 2005 May 15; 17(12):795-803. PubMed ID: 15856178
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiac allograft acceptance after localized bone marrow transplantation by isolated limb perfusion in nonmyeloablated recipients.
    Askenasy N, Yolcu ES, Shirwan H, Wang Z, Farkas DL.
    Stem Cells; 2003 May 15; 21(2):200-7. PubMed ID: 12634416
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T, Hosaka N, Takaki T, Miyake T, Cui W, Inaba M, Kinoshita H, Matsuda T, Ikehara S.
    Bone Marrow Transplant; 2009 Jun 15; 43(11):829-37. PubMed ID: 19079314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.